We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Peripheral Embolization Plug Occludes Small Blood Vessels

By HospiMedica International staff writers
Posted on 14 Jan 2014
A micro vascular plug (MVP) system helps reduce the rate of blood flow in the small vessels of the peripheral vasculature. More...


The MVP-5 micro vascular plug system is designed to occlude vessels quickly and predictably, with a single device delivered via a microcatheter. The self-expanding, ovoid shaped device is comprised of nitinol and is secured at both ends with platinum marker bands and a PTFE partial cover, with the proximal marker band attached to a wire that pushes the device through a microcatheter to the intended treatment site. The delivery wire detaches from the MVP device by electrolytic means after deployment with the proprietary detachment system.

The MVP system is packaged as a single unit with the MVP device, the introducer sheath, and the detachable delivery wire; the MVP device itself is fully re-sheathable to facilitate accurate placement. The proprietary detachment system is intended for multiple uses, and as such is not part of the MVP system. The MVP system and detachment system are products of Reverse Medical (Irvine, CA, USA), and have been approved by the US Food and Drug Administration (FDA).

“Our first procedure with the MVP-5 was impressive, and consistent with our prior experience with the MVP-3, resulting in accurate and immediate vessel occlusion upon deployment,” said assistant professor of interventional radiology Rahul Patel, MD, of Mount Sinai Hospital (New York, NY, USA). “The device tracked easily through tortuous anatomy, allowing for more precise control than conventional embolization coils.”

“The MVP-5 system represents an important addition to the MVP product line worldwide, soon to be followed by an MVP-7 and MVP-9, addressing a broad spectrum of peripheral vascular anatomy,” said Alex Thomson, vice president of global sales at Reverse Medical. “Physician enthusiasm from MVP-3 clinical use created strong demand for larger sizes, and we quickly responded. The MVP is a platform technology with broad clinical utility for peripheral and eventual additional indications throughout the body.”

Related Links:

Reverse Medical



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.